Comparing GFR Estimation Methods in ICU Patients
Author Information
Author(s): Miklós Lipcsey, Mia Furebring, Sten Rubertsson, Anders Larsson
Primary Institution: Uppsala University Hospital
Hypothesis
Is cystatin C a better marker for estimating glomerular filtration rate (GFR) than creatinine and MDRD in ICU patients?
Conclusion
Cystatin C-estimated GFR yields significantly lower results than plasma creatinine and MDRD, indicating that the choice of GFR estimation method can influence treatment decisions in ICU patients.
Supporting Evidence
- 92% of patients had cystatin C-estimated GFR ≤ 80 mL/min/1.73 m2.
- Only 46% of patients had reduced renal function assessed by plasma creatinine alone.
- The mean difference between eGFRMDRD and eGFRcystatinC was 39 mL/min/1.73 m2 for eGFRcystatinC values ≤ 60 mL/min/1.73 m2.
Takeaway
Doctors use different tests to check how well kidneys are working. This study found that one test, called cystatin C, shows more kidney problems than the usual test, creatinine.
Methodology
Retrospective observational study of ICU patients from 2004 to 2006, comparing GFR estimates from creatinine, MDRD, and cystatin C.
Potential Biases
Potential bias in test results due to variations in patient demographics and health conditions.
Limitations
The study is retrospective and may not account for all variables affecting GFR estimation.
Participant Demographics
Patients treated in a general ICU, with a mean age of 62 years; 63% male and 37% female.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website